Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501484PMID: 30000544
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 136310-93-5
Drug Levels and Effects
Summary of Use during Lactation
Although no published data exist on the use of tiotropium, its use produces negligible maternal serum levels and any drug in breastmilk would not be absorbed by the infant. The risk to the breastfed infant of maternal tiotropium inhalation is small.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Tiotropium
CAS Registry Number
136310-93-5
Drug Class
- Breast Feeding
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Muscarinic Antagonists
- Parasympatholytics
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- NMR study on (1alpha, 2beta, 4beta, 5alpha, 7beta)-7-[(hydroxydi-2-thienylacetyl) oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo [3.3.1.0(2,4)] nonane bromide monohydrate.[Spectrochim Acta A Mol Biomol ...]NMR study on (1alpha, 2beta, 4beta, 5alpha, 7beta)-7-[(hydroxydi-2-thienylacetyl) oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo [3.3.1.0(2,4)] nonane bromide monohydrate.Lin Z, Mu Y, Liu Y, Ren Y, Lin J. Spectrochim Acta A Mol Biomol Spectrosc. 2010 Mar; 75(3):1159-62. Epub 2010 Jan 6.
- Review Methscopolamine Bromide.[Drugs and Lactation Database (...]Review Methscopolamine Bromide.. Drugs and Lactation Database (LactMed®). 2006
- Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease.[J Pharmacol Exp Ther. 2009]Smoke, choline acetyltransferase, muscarinic receptors, and fibroblast proliferation in chronic obstructive pulmonary disease.Profita M, Bonanno A, Siena L, Bruno A, Ferraro M, Montalbano AM, Albano GD, Riccobono L, Casarosa P, Pieper MP, et al. J Pharmacol Exp Ther. 2009 May; 329(2):753-63. Epub 2009 Feb 3.
- Review Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.[Drugs. 2014]Review Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.Keating GM. Drugs. 2014 Oct; 74(15):1801-16.
- Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry.[J Proteomics. 2010]Essential tactics of tissue preparation and matrix nano-spotting for successful compound imaging mass spectrometry.Végvári A, Fehniger TE, Gustavsson L, Nilsson A, Andrén PE, Kenne K, Nilsson J, Laurell T, Marko-Varga G. J Proteomics. 2010 Apr 18; 73(6):1270-8. Epub 2010 Mar 1.
- Tiotropium - Drugs and Lactation Database (LactMed®)Tiotropium - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...